AI assistant
MYRIAD GENETICS INC — Director's Dealing 2015
Sep 17, 2015
32566_dirs_2015-09-17_114f6a31-04ec-44ca-9db1-be45241faa81.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: MYRIAD GENETICS INC (MYGN)
CIK: 0000899923
Period of Report: 2015-09-15
Reporting Person: King Gary A. (Exec. VP International Ops)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2015-09-15 | Common Stock | A | 34500.0 | $0.0 | Acquired | 85973 | Direct |
| 2015-09-17 | Common Stock | F | 5400.0 | $41.39 | Disposed | 80573 | Direct |
Footnotes
F1: Consists of restricted stock units granted pursuant to the Company's 2010 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock and vests 25% on September 30, 2016, 25% on September 30, 2017, 25% on September 30, 2018, and 25% on September 30, 2019.
F2: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person.